Evaluation of the effectiveness of a syrup made from sweet Almond in pediatric nocturnal cough with upper respiratory tract infection(common cold) compared to Diphenhydramine: A randomized clinical trial

Iran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年7月16日

适应症

试验速览

暂无简介。

•The patients's age is two to twelve years old
•Cough due to upper respiratory tract infection (common cold) for less than 7 days
•Concomitant symptoms (mild fever: less than 39 ° C, sore throat, cramps, rhinorrhea, mild headache, feeling tired, sneezing
•Do not use any anti-cough product 18 hours before the intervention
•Lack of underlying disease (asthma, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease)
•Conscious written consciously from parents to enter the study
•Possibility of patient Follow up

•Children with signs and symptoms of asthma, pneumonia, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease
•The onset of symptoms of otitis, sinusitis, onset of symptoms of of the lower respiratory tract infection , the addition of a bacterial infection to the viral infection (edema, respiratory problem, severe sore throat with painful ingestion, nausea, vomiting, fever above 39 °, septic nasal discharge, Facial and peri orbital pain) during the intervention
•Lack of allergy (presence of symptoms such as i itchy eye & nose, a history of prolonged cold periods,history of repeating similar symptoms, positive family history of allergy, history of drug and food allergy),
•The presence of sign and symptoms of a Reactive Airway Disease including: tachypnea and tachycardia, short breath, chest tightness )
•Getting any anti cough drug before intervention
•Not using or using irregularly recommended medications
•Add other cough drugs to treatment during the intervention
•allergic reaction to drug combinations during the study
•disrelish to cooperate until the end of the study
•Inaccessibility of the patient during the study

发起方